EXAGEN INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.412 USD | +0.15% |
|
+3.07% | -29.04% |
| Apr. 26 | Exagen Inc. Announces Changes in Board of Directors | CI |
| Mar. 18 | Exagen Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Valuation
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Capitalization 1 | 319 | 167 | 188 | 39.17 | 33.92 | 24.51 | - | - |
| Enterprise Value (EV) 1 | 319 | 167 | 188 | 39.17 | 33.92 | 24.51 | 24.51 | 24.51 |
| P/E ratio | -3 x | -10 x | -6.92 x | -0.87 x | -1.49 x | -1.04 x | -1.36 x | -1.8 x |
| Yield | - | - | - | - | - | - | - | - |
| Capitalization / Revenue | 7.9 x | 3.98 x | 3.89 x | 0.86 x | 0.65 x | 0.45 x | 0.39 x | 0.33 x |
| EV / Revenue | 7.9 x | 3.98 x | 3.89 x | 0.86 x | 0.65 x | 0.45 x | 0.39 x | 0.33 x |
| EV / EBITDA | -36.6 x | -11.4 x | -8.13 x | -1 x | -1.64 x | -1.44 x | -2.3 x | -5.49 x |
| EV / FCF | - | -11.5 x | -8.3 x | -1.07 x | - | -1.33 x | -1.82 x | -3.04 x |
| FCF Yield | - | -8.71% | -12% | -93.1% | - | -74.9% | -54.9% | -32.8% |
| Price to Book | - | 3.99 x | 2.21 x | 0.94 x | - | 5.65 x | -3.21 x | -2.35 x |
| Nbr of stocks (in thousands) | 12,561 | 12,652 | 16,164 | 16,319 | 17,046 | 17,357 | - | - |
| Reference price 2 | 25.40 | 13.20 | 11.63 | 2.400 | 1.990 | 1.412 | 1.412 | 1.412 |
| Announcement Date | 3/25/20 | 3/16/21 | 3/22/22 | 3/20/23 | 3/18/24 | - | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 40.39 | 41.98 | 48.3 | 45.56 | 52.55 | 54.16 | 62.91 | 75.1 |
| EBITDA 1 | -8.708 | -14.64 | -23.12 | -38.99 | -20.67 | -17.02 | -10.65 | -4.467 |
| EBIT 1 | -9.299 | -15.18 | -24.07 | -40.54 | -22.84 | -21.64 | -15.92 | -8.825 |
| Operating Margin | -23.02% | -36.18% | -49.83% | -88.99% | -43.46% | -39.94% | -25.31% | -11.75% |
| Earnings before Tax (EBT) 1 | -12.01 | -16.77 | -26.68 | -47.67 | -23.66 | -24.05 | -19.42 | -14.55 |
| Net income 1 | -30.28 | -16.69 | -26.85 | -47.39 | -23.69 | -24.27 | -19.22 | -14.55 |
| Net margin | -74.97% | -39.75% | -55.59% | -104% | -45.08% | -44.81% | -30.55% | -19.37% |
| EPS 2 | -8.460 | -1.320 | -1.680 | -2.770 | -1.340 | -1.360 | -1.036 | -0.7850 |
| Free Cash Flow 1 | - | -14.54 | -22.64 | -36.46 | - | -18.37 | -13.47 | -8.05 |
| FCF margin | - | -34.64% | -46.87% | -80.03% | - | -33.91% | -21.41% | -10.72% |
| FCF Conversion (EBITDA) | - | - | - | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - | - | - | - |
| Announcement Date | 3/25/20 | 3/16/21 | 3/22/22 | 3/20/23 | 3/18/24 | - | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2021 Q3 | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 12.25 | 12.69 | 10.39 | 8.962 | 14.73 | 12.84 | 11.23 | 14.14 | 13.42 | 13.76 | 13.08 | 13.3 | 13.58 | 14.22 | 14.2 |
| EBITDA 1 | -6.255 | -5.962 | -9.396 | -12.39 | -7.377 | -8.465 | -7.153 | -4.412 | -4.465 | -4.639 | -4.6 | -4.575 | -4.25 | -3.675 | -3.9 |
| EBIT 1 | -6.504 | -6.254 | -9.679 | -12.71 | -7.817 | -8.985 | -7.706 | -4.915 | -5.069 | -5.147 | -5.56 | -5.54 | -5.34 | -4.88 | -5.3 |
| Operating Margin | -53.09% | -49.29% | -93.12% | -141.8% | -53.08% | -69.99% | -68.62% | -34.77% | -37.78% | -37.39% | -42.5% | -41.65% | -39.31% | -34.33% | -37.32% |
| Earnings before Tax (EBT) 1 | -7.179 | -6.878 | -10.27 | -13.31 | -8.096 | -14.64 | -7.688 | -5.013 | -5.415 | -5.54 | -6.3 | -6.3 | -6.1 | -5.5 | -5.9 |
| Net income 1 | -7.179 | -7.053 | -10.27 | -13.31 | -8.096 | -14.35 | -7.688 | -5.013 | -5.415 | -5.573 | -6.3 | -6.3 | -6.1 | -5.5 | -5.9 |
| Net margin | -58.6% | -55.58% | -98.83% | -148.5% | -54.98% | -111.82% | -68.46% | -35.46% | -40.36% | -40.49% | -48.15% | -47.37% | -44.91% | -38.69% | -41.55% |
| EPS 2 | -0.4200 | -0.4200 | -0.6000 | -0.7800 | -0.4700 | -0.8300 | -0.4400 | -0.2800 | -0.3100 | -0.3100 | -0.3620 | -0.3560 | -0.3420 | -0.3080 | -0.3233 |
| Dividend per Share | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Announcement Date | 11/10/21 | 3/22/22 | 5/11/22 | 8/4/22 | 11/14/22 | 3/20/23 | 5/15/23 | 8/7/23 | 11/13/23 | 3/18/24 | - | - | - | - | - |
1USD in Million2USD
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net Debt | - | - | - | - | - | - | - | - |
| Net Cash position | - | - | - | - | - | - | - | - |
| Leverage (Debt/EBITDA) | - | - | - | - | - | - | - | - |
| Free Cash Flow 1 | - | -14.5 | -22.6 | -36.5 | - | -18.4 | -13.5 | -8.05 |
| ROE (net income / shareholders' equity) | - | -34.2% | -42.4% | -74.4% | - | -165% | -253% | - |
| ROA (Net income/ Total Assets) | - | -20% | -26.6% | -45.2% | - | -46.9% | -44.5% | -46.5% |
| Assets 1 | - | 83.34 | 100.9 | 104.8 | - | 51.75 | 43.18 | 31.29 |
| Book Value Per Share 2 | - | 3.310 | 5.250 | 2.570 | - | 0.2500 | -0.4400 | -0.6000 |
| Cash Flow per Share 2 | - | -1.110 | -1.270 | -1.880 | - | -1.110 | -0.8600 | -0.4600 |
| Capex 1 | 0.4 | 0.46 | 2.37 | 4.32 | - | 0.97 | 1.3 | 1.4 |
| Capex / Sales | 1% | 1.08% | 4.91% | 9.48% | - | 1.78% | 2.07% | 1.86% |
| Announcement Date | 3/25/20 | 3/16/21 | 3/22/22 | 3/20/23 | 3/18/24 | - | - | - |
1USD in Million2USD
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
C+
Sell
Buy
Mean consensus
BUY
Number of Analysts
6
Last Close Price
1.412
USD
Average target price
5.5
USD
Spread / Average Target
+289.49%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -29.04% | 24.51M | |
| -14.92% | 84.68B | |
| +13.30% | 81.12B | |
| +10.92% | 29.4B | |
| -12.71% | 16.73B | |
| -3.06% | 16.36B | |
| -2.63% | 14.92B | |
| -31.75% | 11.77B | |
| -1.42% | 11.72B | |
| +27.44% | 11.71B |
- Stock Market
- Equities
- XGN Stock
- Financials Exagen Inc.
